Pantoprazole

Pantoprazole, the active ingredient in this product, is a proton pump inhibitor presented as an injectable solution for intravenous use. It treats conditions related to excess stomach acid such as gastro‑oesophageal reflux disease, erosive esophagitis and Zollinger‑Ellison syndrome, and is used in patients who require rapid acid suppression.

GNH USA supplies Pantoprazole as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor indicated for several acid‑related gastrointestinal conditions.

- Gastro‑oesophageal reflux disease (GERD): reduces acid exposure and promotes healing of the oesophageal lining. - Erosive esophagitis: facilitates ulcer healing and prevents further erosion. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumours. - Prevention of NSAID‑induced gastric ulcers: lowers the risk of ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: typically self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: renal inflammation. - Severe hypersensitivity reactions: rash, angioedema, anaphylaxis. - Low magnesium levels (hypomagnesemia): may cause muscle cramps or cardiac arrhythmia. - Osteoporotic fractures: increased risk with long‑term use. - Liver enzyme elevation: potential hepatic impact.

Before initiating Pantoprazole therapy, consider the following precautions.

- Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor magnesium levels: especially during prolonged treatment. - Evaluate bone health: long‑term use may affect calcium balance. - Pregnancy and lactation: use only if clearly needed; safety data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Pantoprazole can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Ketoconazole: reduced antifungal absorption; avoid concurrent use. - Atazanavir: markedly decreased antiviral levels; avoid.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation. - Digoxin: slight increase in serum concentration; observe for toxicity. - Methotrexate: reduced clearance may raise toxicity risk; adjust dose if needed. - Clopidogrel: diminished antiplatelet effect; consider alternative therapy.